$8.73
0.333.93%
At close: -
$8.73
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Theravance Biopharma Earnings Estimates, EPS & Revenue | NASDAQ:TBPH | Benzinga
Theravance Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 12
EPS Estimate
$-0.090
Quarterly Revenue Estimate
$28.07M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$64.38M
Analyze the earnings history of Theravance Biopharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TBPH | Theravance Biopharma | -$0.09 | -$0.09 | — | — | $14.50M | $28.07M | — | — | 05/12/2025 | Get Alert |
| TBPH | Theravance Biopharma | -$0.17 | -$0.08 | -$0.05 | 37.50% | $17.57M | $17.09M | $18.75M | 9.74% | 02/26/2025 | Get Alert |
| TBPH | Theravance Biopharma | -$0.17 | -$0.23 | -$0.06 | 73.91% | $15.69M | $15.34M | $16.87M | 9.96% | 11/12/2024 | Get Alert |
| TBPH | Theravance Biopharma | -$0.13 | -$0.21 | -$0.13 | 38.10% | $13.75M | $15.45M | $14.26M | -7.73% | 08/05/2024 | Get Alert |
| TBPH | Theravance Biopharma | -$0.24 | -$0.25 | -$0.09 | 64.00% | $10.42M | $13.96M | $14.50M | 3.89% | 05/13/2024 | Get Alert |
| TBPH | Theravance Biopharma | -$0.15 | -$0.15 | -$0.17 | -13.33% | $14.65M | $17.68M | $17.57M | -0.65% | 02/26/2024 | Get Alert |
| TBPH | Theravance Biopharma | -$0.21 | -$0.21 | -$0.17 | 19.05% | $12.45M | $15.00M | $15.69M | 4.62% | 11/07/2023 | Get Alert |
| TBPH | Theravance Biopharma | -$0.04 | -$0.16 | -$0.13 | 18.75% | $11.05M | $15.24M | $13.75M | -9.78% | 08/07/2023 | Get Alert |
| TBPH | Theravance Biopharma | -$0.33 | -$0.26 | -$0.24 | 7.69% | $13.20M | $13.84M | $10.42M | -24.73% | 05/08/2023 | Get Alert |
| TBPH | Theravance Biopharma | -$0.18 | -$0.17 | -$0.21 | -23.53% | $14.95M | $15.73M | $14.65M | -6.87% | 02/27/2023 | Get Alert |
| TBPH | Theravance Biopharma | -$0.46 | -$0.18 | -$0.21 | -16.67% | $13.19M | $12.05M | $12.45M | 3.33% | 11/07/2022 | Get Alert |
| TBPH | Theravance Biopharma | -$0.80 | -$0.03 | -$0.04 | -33.33% | $12.91M | $12.41M | $11.05M | -10.96% | 08/04/2022 | Get Alert |
| TBPH | Theravance Biopharma | -$1.24 | -$0.11 | -$0.22 | -100.00% | $14.26M | $14.48M | $13.20M | -8.87% | 05/05/2022 | Get Alert |
| TBPH | Theravance Biopharma | -$0.92 | -$0.33 | -$0.18 | 45.45% | $18.73M | $13.48M | $14.95M | 10.87% | 02/23/2022 | Get Alert |
| TBPH | Theravance Biopharma | -$1.16 | -$0.55 | -$0.46 | 16.36% | $18.26M | $14.69M | $13.19M | -10.18% | 11/03/2021 | Get Alert |
| TBPH | Theravance Biopharma | -$1.00 | -$1.01 | -$0.80 | 20.79% | $15.01M | $15.41M | $12.91M | -16.20% | 08/03/2021 | Get Alert |
| TBPH | Theravance Biopharma | -$1.14 | -$1.05 | -$1.24 | -18.10% | $19.86M | $17.27M | $14.26M | -17.45% | 05/04/2021 | Get Alert |
| TBPH | Theravance Biopharma | -$1.17 | -$1.02 | -$0.92 | 9.80% | $29.50M | $20.85M | $18.73M | -10.17% | 02/23/2021 | Get Alert |
| TBPH | Theravance Biopharma | -$1.05 | -$0.97 | -$1.16 | -19.59% | $12.43M | $18.58M | $18.26M | -1.74% | 11/05/2020 | Get Alert |
| TBPH | Theravance Biopharma | -$0.72 | $0.98 | -$1.00 | -202.04% | $26.15M | $19.64M | $15.01M | -23.58% | 08/06/2020 | Get Alert |
| TBPH | Theravance Biopharma | -$1.32 | -$1.07 | -$1.14 | -6.54% | $5.34M | $18.13M | $19.86M | 9.55% | 05/06/2020 | Get Alert |
Theravance Biopharma (TBPH) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-26 | $-0.05 | $-0.08 | 37.5 % |
| Q3 | 2024-11-12 | $-0.06 | $-0.23 | 73.9 % |
| Q2 | 2024-08-05 | $-0.13 | $-0.21 | 38.1 % |
| Q1 | 2024-05-13 | $-0.09 | $-0.25 | 64.0 % |
Theravance Biopharma (TBPH) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-26 | $18.75M | $17.09M | 9.74 % |
| Q3 | 2024-11-12 | $16.87M | $15.34M | 9.96 % |
| Q2 | 2024-08-05 | $14.26M | $15.45M | -7.73 % |
| Q1 | 2024-05-13 | $14.50M | $13.96M | 3.89 % |
FAQ
When is Theravance Biopharma (NASDAQ:TBPH) reporting earnings?
Theravance Biopharma (TBPH) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on February 26, 2025 for Q4.
What were the latest earnings per share (EPS) for Theravance Biopharma (NASDAQ:TBPH)?
The Actual EPS was $-0.05, which beat the estimate of $-0.08.
What were Theravance Biopharma’s (NASDAQ:TBPH) revenues?
The Actual Revenue was $18.8M, which beat the estimate of $17.1M.
Browse earnings estimates, EPS, and revenue on all stocks.